Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2000
12/20/2000EP1060259A2 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs
12/20/2000EP1060257A1 Method for the induction of pathogen resistance in plants
12/20/2000EP1060256A1 Novel sphingosine-1 phosphate lyase
12/20/2000EP1060254A2 Human proteinase molecules
12/20/2000EP1060252A2 Human platelet heparanase polypeptides, polynucleotide molecules that encode them, and methods for the identification of compounds that alter heparanase activity
12/20/2000EP1060251A2 Phosphodiesterase 10
12/20/2000EP1060248A1 Lectomedin materials and methods
12/20/2000EP1060247A1 Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response
12/20/2000EP1060193A2 Cd147 binding molecules as therapeutics
12/20/2000EP1060184A1 Best's macular dystrophy gene
12/20/2000EP1059944A1 Detector molecule for use in a method for detecting and surgically removing lymphoid tissue involved in tumor progression
12/20/2000EP0991667A4 Antibodies to cryptosporidium
12/20/2000CN1277632A Natural human antibody
12/20/2000CN1277616A Peptides capable of inhibiting the interaction between presenilins and the beta-amyloid peptide or its precursor
12/20/2000CN1277556A Application of TNF antagonists as medicaments for treating septic diseases
12/20/2000CN1059705C Composition for introducing nucleic acid complexes into higher eucaryotic cells
12/19/2000US6162963 Generation of Xenogenetic antibodies
12/19/2000US6162931 Fluorinated xanthene derivatives
12/19/2000US6162904 Manufacturing method for intraveneously administrable immune globulin and resultant product
12/19/2000US6162902 Reactive to epitopes of human brain natriuretic peptide; rapid and sensitive quantification in plasma or serum
12/19/2000US6162900 Amino acid sequences of polypeptide which transports cadmium, iron(ii), cobalt, manganese, lead, mercury, and zinc; transgenic plants with increased metal uptake for use as nutrient supplements or removing toxic metals from soils
12/19/2000US6162898 Mutant Rev transdominant repressors of HIV replication
12/19/2000US6162620 Nucleotide sequences coding human cytomegalo viral polypeptides; for the development of preventative against human cytomegalo viral infection
12/19/2000US6162618 Nucleotide sequence; recombinant production; diagnosis of infections; drug screening; bactericides; bacteriostats; enzyme inhibitors; vaccines
12/19/2000US6162612 Enzymatic polypeptide; for te detection of enzyme inhibitor which can be used to treat cancer, psoriasis and vascular system defects; anticarcinogenic agents
12/19/2000US6162608 Nuclear matrix protein fluid assay
12/19/2000US6162441 Method for the production of anti-escherichia. coli O157 : H7 antibody
12/19/2000US6162435 A isolated protein for treating swine; a diagnostic test kit for detecting the presence of bacterial infection in swine herds
12/19/2000US6162432 Increased t cell activation and abnormal antigen in the dermis and epidermis
12/19/2000US6162431 Serine/threonine protein kinase
12/19/2000CA2067244C Monoclonal antibody specific for iga receptor
12/19/2000CA2053206C Monoclonal antibodies against melanoma
12/19/2000CA2000420C Peptides representing epitopic sites on r-ifn-beta, antibodies thereto, and uses thereof
12/14/2000WO2000075665A1 Early detection of flaviviruses using the ns1 glycoprotein
12/14/2000WO2000075659A1 Antibodies to nucleus pulposus in disc herniation, diagnostic kit, medical preparations and treatment
12/14/2000WO2000075658A2 Detection of ryanodine receptor antibodies
12/14/2000WO2000075375A1 26 human secreted proteins
12/14/2000WO2000075348A1 Recombinant anti-cd40 antibody and uses thereof
12/14/2000WO2000075345A1 Recombinant fusion protein, (vaccine) composition containing the same and method for the production thereof
12/14/2000WO2000075333A1 Streptavidin expressed gene fusions and methods of use thereof
12/14/2000WO2000075328A1 Human sel-10 polypeptides and polynucleotides that encode them
12/14/2000WO2000075327A1 Methods and compositions for inhibiting neoplastic cell growth
12/14/2000WO2000075323A1 Tek antagonists
12/14/2000WO2000075319A1 Modified chimeric polypeptides with improved pharmacokinetic properties
12/14/2000WO2000075318A1 Phospholipid transfer protein
12/14/2000WO2000075317A2 Compositions and methods for the treatment of tumor
12/14/2000WO2000075316A1 Methods and compositions for inhibiting neoplastic cell growth
12/14/2000WO2000075312A1 Cd44 splice variant associated with rheumatoid arthritis
12/14/2000WO2000075305A2 Candida albicans genes and proteins coded by said genes
12/14/2000WO2000075300A2 Methods for manipulating the avian genome
12/14/2000WO2000075278A2 Gene encoding nade, p75ntr-associated cell death executor and uses thereof
12/14/2000WO2000075191A2 Apo-2L RECEPTOR AGONIST AND CPT-11 SYNERGISM
12/14/2000WO2000075190A2 Hybridomas for lung cancer marker and monoclonal antibodies thereof
12/14/2000WO2000075187A1 An integrin heterodimer and an alpha subunit thereof
12/14/2000WO2000075183A1 Product from starfish
12/14/2000WO2000075175A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
12/14/2000WO2000075173A2 Peptide fragments of colostrinin
12/14/2000WO2000075163A1 Angiogenic proteins and uses thereof
12/14/2000WO2000074729A2 Alpha or beta emitters to fragments in radioimmunotherapy
12/14/2000WO2000074728A1 Novel reagents for detection and purification of antibody fragments
12/14/2000WO2000074722A2 Modification of biological elements
12/14/2000WO2000074719A1 Method of treating carcinoma using antibody therapy and ameliorating side effects associated with such therapy
12/14/2000WO2000074718A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000WO2000074717A1 NOVEL Ig FRACTIONS HAVING AN IMMUNOMODULATORY ACTIVITY
12/14/2000WO2000074705A1 Rheumatic autoimmune disease antigen
12/14/2000WO2000074703A2 Therapeutic agent comprising a botulinum neurotoxin
12/14/2000WO2000074688A1 Methods for preventing formation of inhibitory antibodies in the setting of gene therapy
12/14/2000WO2000074634A2 Methods and compositions for modulating cell proliferation and cell death
12/14/2000WO2000053776A3 Human kallikrein-like genes
12/14/2000WO2000053749A3 Vascular adhesion molecules and modulation of their function
12/14/2000WO2000050562A3 Dna encoding snorf25 receptor
12/14/2000WO2000050070A3 Preparation for the treatment of pigmentation disorders
12/14/2000WO2000048681A3 Co-administration of a thrombolytic and an anti-cd18 antibody
12/14/2000WO2000047231A3 Novel antisense inhibition of rad51
12/14/2000WO2000046236A3 Novel rgs-containing molecules and uses thereof
12/14/2000WO2000043032A3 Baff, inhibitors thereof and their use in the modulation of b-cell response
12/14/2000WO2000042063A3 Peptides for inhibiting hbv core proteins
12/14/2000CA2504679A1 Compositions and methods for the treatment of tumor
12/14/2000CA2501815A1 Compositions and methods for the treatment of tumor
12/14/2000CA2390090A1 Peptides
12/14/2000CA2383828A1 26 human secreted proteins
12/14/2000CA2377385A1 Methods and compositions for modulating cell proliferation and cell death
12/14/2000CA2376335A1 Novel ig fractions having an immunomodulatory activity
12/14/2000CA2376192A1 Streptavidin expressed gene fusions and methods of use thereof
12/14/2000CA2376179A1 Method of treating carcinoma using antibody therapy and ameliorating side effects associated with such therapy
12/14/2000CA2376078A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
12/14/2000CA2376018A1 Angiogenic proteins and uses thereof
12/14/2000CA2375912A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000CA2375876A1 An integrin heterodimer and an alpha subunit thereof
12/14/2000CA2375441A1 Methods for manipulating the avian genome
12/14/2000CA2375149A1 Apo-2l receptor agonist and cpt-11 synergism
12/14/2000CA2374851A1 Tek antagonists
12/14/2000CA2374587A1 Hybridomas for lung cancer marker and monoclonal antibodies thereof
12/14/2000CA2374558A1 Phospholipid transfer protein
12/14/2000CA2374001A1 Alpha or beta emitters attached to fragments in radioimmunotherapy
12/14/2000CA2373356A1 Detection of ryanodine receptor antibodies
12/14/2000CA2371434A1 Compositions and methods for the treatment of tumor
12/13/2000EP1059533A1 Method for immunochemically assaying anti-hm1.24 antibody
12/13/2000EP1059089A1 Preventives/remedies for inflammatory intestinal disease
12/13/2000EP1059088A1 New Ig-fractions with immunomodulation activity
1 ... 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 ... 1494